Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132050) titled 'The SAMD9/STAT1 axis regulates tumor-promoting mechanisms of pancreatic cancer stem cells in a circadian' on Sept. 9.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: The First Affiliated Hospital of Chongqing Medical University
Condition:
pancreatic cancer
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-10
Target Sample Size: Observation group:60;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=334514
Published by HT Digital Content Services with permission from Health Daily Digest....